Keywords: positive, ph, iii, data, cephalon, nuvigil, usa-based

Positive Ph III data for Cephalon's Nuvigil

Article | 21 February 2005

Print This

USA-based drugmaker Cephalon says that Phase III studies of 150mg and 250mg daily doses of its Nuvigil (armodafinil) in patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in